semaglutide release date The upcoming expiry of the patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open More than 170,000 people in

However, this medication isn't recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

This step-up approach helps the body adjust and may reduce stomach-related side effects such as nausea

That is why many guidelines suggest an eye check and careful monitoring if someone already has significant diabetic retinopathy

Both substances influence metabolic pathwaysWegovy through its action on appetite regulation and glucose metabolism, and inositol through its role in insulin signalling and cellular function

Administered via subcutaneous injection, it crosses the blood-brain barrier to act on various regions of the hypothalamus, including the arcuate nucleus